secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pelthos Therapeutics Inc. (PTHS)
CIK:        0001919246
Form:       8-K
Filed at:   2025-03-03T23:59:59+00:00
Accession:  0001753926-25-000376
Event type: debt
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Channel Therapeutics issues $325K promissory note to 3i, L.P. at $250K purchase price
--------------------------------------------------------------------------------

- Issued $325,000 principal unsecured note to 3i, L.P. for $250,000 purchase price (approx. 23% discount).
- Interest at 6.0% simple p.a.; maturity on May 25, 2025 or upon Corporate Event or default.
- Prepayable without penalty on 2 days' notice; proceeds for general working capital.
- Note is unsecured; contains standard Events of Default and no stockholder rights.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1919246/000175392625000376/0001753926-25-000376-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1919246/000175392625000376/g084719_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-25-000376

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer